AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

BACKGROUND: The androgen-receptor isoform encoded by splice variant 7 lacks the ligand-binding domain, which is the target of enzalutamide and abiraterone, but remains constitutively active as a transcription factor. We hypothesized that detection of androgen-receptor splice variant 7 messenger RNA...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonarakis, Emmanuel S., Lu, Changxue, Wang, Hao, Luber, Brandon, Nakazawa, Mary, Roeser, Jeffrey C., Chen, Yan, Mohammad, Tabrez A., Chen, Yidong, Fedor, Helen L., Lotan, Tamara L., Zheng, Qizhi, De Marzo, Angelo M., Isaacs, John T., Isaacs, William B., Nadal, Rosa, Paller, Channing J., Denmeade, Samuel R., Carducci, Michael A., Eisenberger, Mario A., Luo, Jun
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201502/
https://ncbi.nlm.nih.gov/pubmed/25184630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1315815
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items